ZEMDAP® Tablet

ZEMDAP® contains Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus. Beyond blood sugar control, it offers proven cardiovascular and renal protection, reducing the risk of heart failure hospitalizations and slowing the progression of chronic kidney disease. It is effective both as monotherapy or in combination with other oral antidiabetics.

Categories: ,

Description

Composition (Each Film-Coated Tablet Contains):

  • ZEMDAP® 5: Dapagliflozin 5 mg

  • ZEMDAP® 10: Dapagliflozin 10 mg

Category: Diabetes Care / SGLT2 Inhibitors / Cardio-Renal Protection
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu or Blister Pack


Product Description:

ZEMDAP® contains Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus. Beyond blood sugar control, it offers proven cardiovascular and renal protection, reducing the risk of heart failure hospitalizations and slowing the progression of chronic kidney disease. It is effective both as monotherapy or in combination with other oral antidiabetics.


Key Benefits:

  • Promotes urinary glucose excretion and lowers blood sugar

  • Aids in weight loss and reduces systolic blood pressure

  • Cardioprotective in patients with diabetes and heart failure

  • Renoprotective in patients with CKD

  • Once-daily dosing with minimal risk of hypoglycemia


How it works:

Dapagliflozin works by blocking SGLT2 receptors in the proximal renal tubules, reducing glucose reabsorption in the kidneys and promoting glucosuria (urinary glucose excretion). This leads to improved glycemic control, calorie loss, and reduction in body weight and blood pressure.


How to use:

  • Take one tablet once daily, preferably in the morning, with or without food.

  • Swallow whole with water — do not crush or split.

  • Dose selection (5mg or 10mg) depends on the clinical condition and the doctor’s judgment.

  • Maintain adequate fluid intake while on this medication.


Safety Advice:

  • May increase urination frequency — stay well hydrated.

  • Monitor renal function, blood glucose, and HbA1c regularly.

  • Low risk of hypoglycemia unless used with insulin or sulfonylureas.

  • Inform your doctor if symptoms of UTI, genital infection, or dizziness occur.


Precautions:

  • Not recommended in patients with type 1 diabetes or diabetic ketoacidosis.

  • Use with caution in patients with recurrent UTIs, hypotension, or renal impairment.

  • Avoid during pregnancy and lactation unless clearly indicated.

  • Inform your doctor of all ongoing medications, especially diuretics, insulin, or RAAS inhibitors.


Storage:

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight.
Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “ZEMDAP® Tablet”

Your email address will not be published. Required fields are marked *